KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Change in Accured Expenses (2016 - 2025)

Quest Diagnostics (DGX) has disclosed Change in Accured Expenses for 17 consecutive years, with $16.0 million as the latest value for Q4 2025.

  • Quarterly Change in Accured Expenses fell 54.29% to $16.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $129.0 million through Dec 2025, up 292.54% year-over-year, with the annual reading at $129.0 million for FY2025, 292.54% up from the prior year.
  • Change in Accured Expenses hit $16.0 million in Q4 2025 for Quest Diagnostics, down from $124.0 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $235.0 million in Q3 2021 to a low of -$211.0 million in Q1 2023.
  • Historically, Change in Accured Expenses has averaged -$5.4 million across 5 years, with a median of $12.5 million in 2024.
  • Biggest five-year swings in Change in Accured Expenses: surged 2100.0% in 2022 and later tumbled 334.38% in 2023.
  • Year by year, Change in Accured Expenses stood at -$1.0 million in 2021, then soared by 2100.0% to $20.0 million in 2022, then skyrocketed by 780.0% to $176.0 million in 2023, then crashed by 80.11% to $35.0 million in 2024, then tumbled by 54.29% to $16.0 million in 2025.
  • Business Quant data shows Change in Accured Expenses for DGX at $16.0 million in Q4 2025, $124.0 million in Q3 2025, and $42.0 million in Q2 2025.